Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease

European Neurology

Volumn 49, Issue 3, 2003, Pages 142-145

  Lee, Yi Chung ^a,b   Liu, Ren Shyan ^a   Liao, Yi Chu ^a,b   Sun, Chen Ming ^a   Wang, Po Shan ^a,b   Wang, Pei Ning ^a,b   Liu, Hsiu Chih ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; SPECT; Statistical parametric mapping

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PARIETAL LOBE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0345268723     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069086     Document Type: Article

References (16)

1. Nitrini R, Buchpiguel CA, Caramelli P, Bahia VS, Mathias SC, Nascimento CMR, Degenszajn J, Caixeta L: SPECT in Alzheimer's disease: Features associated with bilateral parietotemporal hypoperfusion. Acta Neurol Scand 2000;101:172-176.
2. Stern Y, Alexander GE, Prohovnik I, Mayeux R: Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-375.
3. Van Gool WA, Walstra GJM, Teunisse S, Van der Zant FM, Weinstein HC, Van Royen EA: Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography. J Neurol 1995;242:401-405.
4. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-1162.
5. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
7. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
8. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, White LR: The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58.
9. Hsiu-Chih Liu, Evelyn Lee Teng, Ker-Neng Lin, Ya-Yun Chuang, Pei-Ning Wang, Jong-Ling Fuh, Chia-Yiu Liu: Performance on the Cognitive Abilities Screening Instrument at different stages of Alzheimer's disease. Dement Geriatr Cogn Disord 2002;13:244-248.
10. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, and Frackowiak RSJ: Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapping 1995;2:189-210.
11. Talairach J, Tournoux P: Co-Planar Stereotactic Atlas of the Human Brain. Stuttgart, Thieme, 1988.
12. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
13. Bobinski M, Leon MJ, Convit A, Santi S, Wegiel J, Tarshish CY, Louis LAS, Wisniewski HM: MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999:353:38-40.
14. Jack CR, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
15. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E: Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med 1998;39:293-298.
16. Pickut BA. Dierckx RA. Dobbeleir A, Audenaert K, Van Laere K, Vervaet A, De Deyn PP: Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 1999;90:103-112.